PURPLE INNOVATION INC (PRPL) Stock Analyst Ratings
NASDAQ:PRPL - Nasdaq - US74640Y1064 - Common Stock
ChartMill assigns a Buy % Consensus number of 73% to PRPL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.02. This target is 70.43% above the current price.
PRPL was analyzed by 14 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about PRPL.
In the previous month the buy percentage consensus was at a similar level.
PRPL was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-04 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-08-06 | Craig-Hallum | Maintains | Hold -> Hold |
| 2024-05-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-03-13 | Roth MKM | Upgrade | Neutral -> Buy |
| 2024-03-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-13 | Craig-Hallum | Maintains | Hold -> Hold |
| 2024-03-07 | Roth MKM | Maintains | Neutral -> Neutral |
| 2024-01-24 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-01-24 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-13 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-11-10 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-11-10 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-08-25 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-04-14 | Wedbush | Reiterate | Outperform |
| 2023-03-21 | UBS | Maintains | Neutral |
| 2023-02-01 | Keybanc | Maintains | Overweight |
| 2023-01-12 | Keybanc | Maintains | Overweight |
| 2022-11-10 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2022-09-20 | Keybanc | Maintains | Overweight |
| 2022-09-20 | Wedbush | Maintains | Outperform |
| 2022-03-02 | Keybanc | Maintains | Overweight |
| 2022-03-02 | Roth Capital | Downgrade | Buy -> Neutral |
| 2021-12-14 | Keybanc | Maintains | Overweight |
| 2021-12-14 | Wedbush | Maintains | Outperform |
| 2021-11-10 | UBS | Downgrade | Buy -> Neutral |
| 2021-11-10 | Keybanc | Maintains | Overweight |
| 2021-11-10 | B. Riley Securities | Downgrade | Buy -> Neutral |